These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23306370)

  • 1. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy.
    Meregaglia M; Ferrara L; Melegaro A; Demicheli V
    Vaccine; 2013 Feb; 31(8):1135-7. PubMed ID: 23306370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization.
    Skowronski DM; Janjua NZ; Tsafack EP; Ouakki M; Hoang L; De Serres G
    Clin Infect Dis; 2012 Feb; 54(3):318-27. PubMed ID: 22156850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit of the introduction of new strategies for vaccination against pertussis in Spain: cocooning and pregnant vaccination strategies.
    Fernández-Cano MI; Armadans Gil L; Campins Martí M
    Vaccine; 2015 May; 33(19):2213-2220. PubMed ID: 25825331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands.
    Westra TA; de Vries R; Tamminga JJ; Sauboin CJ; Postma MJ
    Clin Ther; 2010 Aug; 32(8):1479-95. PubMed ID: 20728761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.
    Scuffham PA; McIntyre PB
    Vaccine; 2004 Jul; 22(21-22):2953-64. PubMed ID: 15246632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia.
    Foxwell AR; McIntyre P; Quinn H; Roper K; Clements MS
    Pediatr Infect Dis J; 2011 Feb; 30(2):161-3. PubMed ID: 20811313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cocoon immunisation strategy against pertussis for infants: does it make sense for Ontario?
    Lim GH; Deeks SL; Crowcroft NS
    Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent and adult pertussis vaccination: computer simulations of five new strategies.
    Van Rie A; Hethcote HW
    Vaccine; 2004 Aug; 22(23-24):3154-65. PubMed ID: 15297068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis.
    Iskedjian M; De Serres G; Einarson TR; Walker JH
    Vaccine; 2010 Jan; 28(3):714-23. PubMed ID: 19895923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.
    Lugnér AK; van der Maas N; van Boven M; Mooi FR; de Melker HE
    Vaccine; 2013 Nov; 31(46):5392-7. PubMed ID: 24075918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.
    Kolos V; Menzies R; McIntyre P
    Vaccine; 2007 Jan; 25(4):588-90. PubMed ID: 16971026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free vaccine programs to cocoon high-risk infants and children against influenza and pertussis.
    Guzman-Cottrill JA; Phillipi CA; Dolan SA; Nyquist AC; Win A; Siegel J
    Am J Infect Control; 2012 Nov; 40(9):872-6. PubMed ID: 23116758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis in early infancy: disease burden and preventive strategies.
    McIntyre P; Wood N
    Curr Opin Infect Dis; 2009 Jun; 22(3):215-23. PubMed ID: 19395958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of parental cocooning as a vaccination strategy to prevent pertussis infection in infants: A case-control study.
    Rowe SL; Tay EL; Franklin LJ; Stephens N; Ware RS; Kaczmarek MC; Lester RA; Lambert SB
    Vaccine; 2018 Apr; 36(15):2012-2019. PubMed ID: 29525284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis hospitalizations among infants in the United States, 1993 to 2004.
    Cortese MM; Baughman AL; Zhang R; Srivastava PU; Wallace GS
    Pediatrics; 2008 Mar; 121(3):484-92. PubMed ID: 18310196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.
    van Hoek AJ; Campbell H; Amirthalingam G; Andrews N; Miller E
    J Infect; 2016 Jul; 73(1):28-37. PubMed ID: 27108802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lifelong protection against pertussis].
    Riffelmann M; Wirsing von König CH
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S86-9. PubMed ID: 19353478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.